Northwestern Mutual Wealth Management’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Other funds holding BBH
MIM
CCA
BFG
Northwestern Mutual Wealth Management's BBH Position: Q2 2026 in Review
Northwestern Mutual Wealth Management reduced its VanEck Biotech ETF (BBH) stake by 18% in Q2 2026, selling an estimated $28.6K and leaving 702 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #2126.
Northwestern Mutual Wealth Management first reported a position in BBH in Q2 2014 and has held it in 27 quarters since. The position peaked at $4.36M in Q3 2024. 110 funds tracked by Wall St. Rank hold BBH as of Q2 2026.
- Northwestern Mutual Wealth Management held 702 shares of VanEck Biotech ETF worth $143K as of Q2 2026.
- Northwestern Mutual Wealth Management sold 152 VanEck Biotech ETF shares in Q2 2026, an estimated $28.6K.
- VanEck Biotech ETF made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #2126 holding.
- Northwestern Mutual Wealth Management first reported a position in VanEck Biotech ETF in Q2 2014 and has held it in 27 quarters since.
- Northwestern Mutual Wealth Management's VanEck Biotech ETF position peaked at $4.36M in Q3 2024.
- 110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.